Abu Dhabi has successfully given its first-ever gene therapy injection to patients with inherited blood disorders, such as severe sickle cell disease and beta thalassaemia. This new treatment, called CASGEVY, works by correcting the faulty gene that causes these conditions, offering long-term relief by addressing the underlying cause rather than just treating the symptoms.
The therapy is available to patients who are 12 years old and above. It can be accessed through insurance and reimbursement programs, making it more accessible to those who need it. The procedure was performed at the Yas Clinic in Khalifa City, in collaboration with the Abu Dhabi Stem Cells Center, marking an important step forward in medical treatment for these blood disorders.
This groundbreaking treatment has the potential to significantly improve the quality of life for patients suffering from these inherited diseases, offering hope for a future where they don’t have to rely on ongoing symptom management. It’s worth noting that this information is provided for informational purposes based on available reports, and the image included is for reference. For more details, it’s always best to visit official sources.
